Authors


Lin Jin, MB

Latest:

Current Status and Influencing Factors of Nursing Interruption Events

This study investigated the current status of nursing interruption events and analyzed the time costs, priority of events, and factors influencing interruptions.


Jack LaViolette, MSc

Latest:

Community Health Workers’ Critical Role in Trust Building Between the Medical System and Communities of Color

The authors interrogate elements of routine medical practice in New York City to argue for reforms of hospital culture through relational trust-building capabilities of community health workers.


Katy Kaplan, PhD

Latest:

The Implementation of Opioid Prescribing Report Cards in Medicaid Managed Care: A Community Quality Collaborative

This article describes the Philadelphia Medicaid Opioid Prescribing Initiative that was launched by a multidisciplinary team and mailed local Medicaid providers individualized prescribing report cards.


Tavajay Campbell, PharmD, BCACP

Latest:

Charitable Medication Distribution Improves Care for Uninsured Patients With Diabetes

This report illustrates how providing vital diabetes medications to uninsured patients through a charitable medication distributor improves clinical outcomes.


Sylvia Garay, MD

Latest:

Social Determinants of Health Score: Does It Help Identify Those at Higher Cardiovascular Risk?

Calculating a social score is feasible and it predicts cardiovascular outcomes. In order to do this, institutions have to collect social determinants of health.


Xiao Chen, PhD

Latest:

Intersection of Complexity and High Utilization Among Health Center Patients Aged 18 to 64 Years

This paper utilizes latent class analysis to identify subgroups of complex conditions and of super-utilizers among health center patients to inform clinically tailored efforts.


Yolande M. Pengetnze, MD

Latest:

Timely Preterm-Birth Prediction Among Pregnant Women in Medicaid Without Preterm-Birth History

A novel prediction model is developed that accurately predicts preterm birth in a timely manner among pregnant women in Medicaid without preterm-birth history.



Ira B. Wilson, MD, MSc

Latest:

Medicaid Expansion, Managed Care Plan Composition, and Enrollee Experience

Medicaid expansion was associated with substantial changes in Medicaid managed care plan composition, which may influence a plan’s performance on enrollee experience metrics.


Lindsay Musial, PharmD

Latest:

Prior Authorization Requirements for Calcitonin Gene-Related Peptide Antagonists

This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.


Katie S. Murray, DO

Latest:

Final Panel Thoughts on Uncomplicated UTI Management

Panelists discuss how the management of uncomplicated urinary tract infections (UTIs) is evolving, with promising new therapies that address antibiotic resistance concerns, while emphasizing the continued importance of antimicrobial stewardship, personalized treatment approaches, preventive strategies, and comprehensive patient education to reduce recurrence rates and improve outcomes in this common but burdensome condition.


Susan Cahn, DrPH

Latest:

Use of Voluntary Alignment in the Next Generation ACO Model

Use of voluntary alignment attribution by Next Generation Accountable Care Organization (ACO) participants was limited. The authors highlight the reasons and describe organizational use cases via a mixed-methods approach.


Colin Banas, MD, MHA | Image Credit: DrFirst
Colin Banas, MD, MHA

Latest:

Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays

Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.


Thomas G. Weiss, BS

Latest:

Differences in Spending for Diabetes and Multiple Chronic Conditions in Michigan Medicare Beneficiaries

Diabetes and multiple chronic conditions increase overall Medicare spending, but spending increases even more in minority beneficiaries compared with White beneficiaries with similar comorbidity combinations.


Michelle Winkler, PhD, MPH

Latest:

Rituximab Reference vs Biosimilar Utilization for Oncology vs Nononcology Indications

Reporting on the real-world utilization of reference rituximab and its biosimilars can help show prescribing habits and reveal cost-saving opportunities.


Sarah R. MacEwan, PhD

Latest:

Relationships Between Patient Portal Activation and Patient Satisfaction Scores Among CG-CAHPS and HCAHPS Respondents

Patients with activated patient portal accounts report higher patient satisfaction in respective dimensions of the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) and Hospital CAHPS (HCAHPS) surveys compared with patients without portal accounts.


Akira Nishii, BS

Latest:

Patient-Centered Communication, Disparities, and Patient Portals in the US, 2017-2022

From 2017 to 2022, patients with better communication with providers were more likely to report being offered and accessing a patient portal, but disparities persist.


Victoria Johnson

Latest:

TPIP a Potential Game-Changer for Prostanoid Therapy in PAH

Treprostinil palmitil inhalation powder (TPIP) for pulmonary arterial hypertension (PAH) showed promising results in a midstage clinical trial, significantly improving key measures of heart and lung function.


Ruben Mesa, MD

Latest:

Management of MPN: Benchmarks For Quality Care

Ruben Mesa, MD, leads a discussion on key benchmarks and final thoughts about good-quality care programs for patients with MPNs, including parameters for judging efficacy and safety.


John Michael O’Brien, PharmD, MPH | Image Credit: © National Pharmaceutical Council
John Michael O’Brien, PharmD, MPH

Latest:

Contributor: Beyond the Sloganeering—A Data-Driven Analysis of Recent 340B Growth

This contributor column discusses a recent study that shows the 340B Program’s explosive growth is overwhelmingly due to utilization increases, not price.


Ann Marie Huffenberger, DBA

Latest:

An Accelerated Hospital Observation Pathway to Reduce Length of Stay for Patients With COVID-19

For select patients hospitalized due to COVID-19, an academic urban hospital implemented an observation pathway that incorporated mobile health technology, reducing hospital length of stay by more than 2 days.


Tom Belmont | image credit: LinkedIn
Tom Belmont

Latest:

GPBCH Annual Conference Will Feature Innovation and Policy Insights

Employers explore innovative strategies at the Greater Philadelphia Business Coalition on Health (GPBCH) Annual Conference, focusing on GLP-1 policies to enhance health care quality and manage costs effectively.


Michael J. Crossey, MD, PhD

Latest:

Leveraging Longitudinal Clinical Laboratory Results to Improve Prenatal Care

Collaboration between a clinical laboratory and a managed care organization improved prenatal care and outcomes through real-time, actionable, laboratory-derived insights and care coordination.


JC Scott

Latest:

Biosimilar Adoption, Legislative Action With PBMs: JC Scott

JC Scott, CEO and president of The Pharmaceutical Care Management Association, discusses current efforts in increasing biosimilar adoption and pharmacy benefit manager (PBM) reform.


Nauman Chaudary, MD, FACP, FCCP

Latest:

Final Thoughts on Bronchiectasis Management

Panelists discuss how bronchiectasis is more common than previously thought, with growing awareness, research, and specialized centers improving diagnosis and treatment options, though challenges remain in standardizing care and securing insurance coverage for therapies.


Steven P. Dehmer, PhD

Latest:

Care Coordination in Primary Care: Mapping the Territory

A survey completed by 100% of leaders of diverse care systems in Minnesota participating in an observational study showed little difference in approach to care coordination.


Dirk Arnold, MD, PhD

Latest:

Exploring Amivantamab's Potential in Colorectal Cancer: Dirk Arnold, MD, PhD

Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre, discusses the trial design of a study comparing amivantamab with standard chemotherapy to potentially improve treatment outcomes.


Ashwin Avhad

Latest:

Contributor: Top 3 Future Therapies to Drive Hemophilia Treatment Market Growth

The trends in the hemophilia treatment market are gaining momentum with increasing incidences of hemophilia A and B and staggering need for their treatments, including gene, anti-tissue factor pathway inhibitor, and factor replacement therapies.


Rachael M. Moloney, MHS

Latest:

Proposed Framework for Patient-Centered Outcomes-Based Measures in Alternative Payment Models

Synthesis of multistakeholder perspectives from a mixed-methods study identifies guiding characteristics for outcomes-based quality measures in future, more patient-centered alternative payment models.


Jonathan Rothwell, PhD

Latest:

Contributor: How Health Care Companies Can Use Upskilling to Navigate the Great Resignation

The Great Resignation is sending health care workers out of the industry in massive numbers, and this, coupled with the ongoing transformation of health care, is creating the perfect storm. Alleviating their stress, burnout, and disengagement is a necessary first step. But the proper development, training, and upskilling is also crucial.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo